Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

ISFAHAN UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran

Country: 🇮🇷Iran

Ownership: Private

Established: 1024-01-01

Employees: -

Market Cap: -

Website: http://www.mui.ac.ir

Clinical Trials

3D Eye Movement Simulator for Medical Education

Not Applicable

Not yet recruiting

Conditions: Education
Education, Medical, Undergraduate
Education, Medical

First Posted Date: 2025-06-22

Last Posted Date: 2025-06-22

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 76

Registration Number: NCT07031960

Construction and Educational Impact of Plastination Models of the Limbic System, Basal Nuclei, Cerebellum, and Human Spinal Cord

Not Applicable

Not yet recruiting

Conditions: Education
Education, Medical
Education, Medical, Undergraduate

First Posted Date: 2025-05-28

Last Posted Date: 2025-05-28

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 60

Registration Number: NCT06991933

Comparative Efficacy of ADM Hydrogel vs. Alginate Dressings in Chronic Trauma Wounds

Not Applicable

Not yet recruiting

Conditions: Trauma Wounds

First Posted Date: 2025-05-18

Last Posted Date: 2025-05-18

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 130

Registration Number: NCT06978569

Locations: 🇮🇷
Alzahra hospital, Isfahan, Iran, Islamic Republic of

The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome

Phase 1

Recruiting

Conditions: PCO - Polycystic Ovaries
Obesity and Obesity-related Medical Conditions

Interventions: Drug: Subjects in the intervention group will receive one capsule containing 10 mg Astaper day made by the "Zyest Technology Tarawat Zendig" institute in Iran. The dosage of ASX is determined based on the s
Drug: Placebo

First Posted Date: 2024-10-15

Last Posted Date: 2024-10-17

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 44

Registration Number: NCT06642363

Locations: 🇮🇷
Isfahan university of medical sciences, Isfahan, Iran, Islamic Republic of

Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin

Phase 2

Recruiting

Conditions: Diabetic Macular Edema
Macular Edema
Retinal Neovascularization

First Posted Date: 2024-09-13

Last Posted Date: 2024-09-13

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 52

Registration Number: NCT06595355

Mesenchymal Stem Cells Derived Exosomes in Osteoarthritis Patients

Not Applicable

Recruiting

Conditions: Osteoarthritis, Knee

Interventions: Biological: Exosome

First Posted Date: 2024-06-20

Last Posted Date: 2024-06-20

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 20

Registration Number: NCT06466850

Locations: 🇮🇷
Leila Dehghani, Isfahan, Iran, Islamic Republic of

Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo Transfer

Phase 1

Active, not recruiting

Conditions: Thin Endometrium
Infertility Female
Infertility

Interventions: Drug: Growh hormone
Other: Placebo

First Posted Date: 2024-04-23

Last Posted Date: 2024-08-13

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 54

Registration Number: NCT06379659

Locations: 🇮🇷
Isfahan Shahid Beheshti hospital, Hazrat e Maryam Fertility Center, Isfahan, Iran, Islamic Republic of

Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK

Phase 2

Completed

Conditions: Photorefractive Keratectomy

Interventions: Drug: prepared drop of medroxy progestrone acetat 1%

First Posted Date: 2023-08-02

Last Posted Date: 2023-08-02

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 74

Registration Number: NCT05973253

Locations: 🇮🇷
Isfahan eyes research centre, Isfahan, Iran, Islamic Republic of
🇮🇷
Isfahan Eye Research Center, Isfahan, Iran, Islamic Republic of

Mesenchymal Stem Cells Derived Exosomes in Skin Rejuvenation

Phase 1

Recruiting

Conditions: Anti Aging

Interventions: Combination Product: exosime injection

First Posted Date: 2023-04-14

Last Posted Date: 2023-04-14

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 20

Registration Number: NCT05813379

Locations: 🇮🇷
Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of

Exosome Effect on Prevention of Hairloss

Not Applicable

Recruiting

Conditions: Hair Loss
Alopecia

Interventions: Device: Exosome

First Posted Date: 2022-12-20

Last Posted Date: 2022-12-20

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 20

Registration Number: NCT05658094

Locations: 🇮🇷
Leila Dehghani, Isfahan, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy